Tandem Diabetes Care Inc reports results for the quarter ended June 30 - Earnings Summary

• Tandem Diabetes Care Inc TNDM.OQ reported a quarterly adjusted loss of 48 cents​​ per share for the quarter ended June 30, identical to the same quarter last year. The mean expectation of twenty three analysts for the quarter was for a loss of 40 cents per share. Wall Street expected results to range from -57 cents to -32 cents per share.

• Revenue rose 8.5% to $240.68 million from a year ago; analysts expected $238.57 million.

• Tandem Diabetes Care Inc's reported EPS for the quarter was a loss of 78 cents​.

• The company reported a quarterly loss of $52.4 million.

• Tandem Diabetes Care Inc shares had fallen by 18.7% this quarter and lost 57.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.2% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 11 "strong buy" or "buy," 11 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Tandem Diabetes Care Inc is $27.00, about 46.7% above its last closing price of $14.39

This summary was machine generated from LSEG data August 6 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)